Prealize Health, an artificial intelligence (AI)-enabled predictive analytics company, today announced the acquisition of CentraForce Health’s intellectual property. The transaction officially closed on August 2, 2022.
The two companies had previously worked together as strategic partners, recognizing the need to develop more holistic profiles of their client’s members, patients, and employees.
Prealize provides a suite of advanced machine learning insights at the individual level, informing on the rising risk and future cost trajectories of populations. Specific insights into the clinical and utilization drivers of that risk, the likelihood of improving outcomes from clinical interventions, and the likelihood to engage enable Prealize customers to activate the right interventions at the right time.
With this SDoH IP acquisition, Prealize now owns the industry’s most robust library of data and insights at the individual level and can provide a comprehensive view of an individual’s medical, ethnographic, socioeconomic, social determinant, and behavioral and attitudinal risks along with their engagement profile. These Comprehensive Determinants of Health™ directly impact access, while driving health consumption and total cost of care.
Also Read: Quectel supports India’s 5G roll-out with IoT modules, antennas and services
“At Prealize, we help payers and providers understand the future and ultimately change the health trajectories of individual members and patients by accurately predicting their future health events, as well as their receptiveness to earlier care,” said Linda Hand, CEO, Prealize Health. “Our acquisition of this intellectual property from CentraForce Health, their revolutionary data analytics engine, and their proprietary technology further positions us as the industry leader in predictive analytics.”
“Being able to access previously unknowable insights allows health providers to more deeply understand the behaviors that contribute to the onset of chronic diseases, and reduce or potentially prevent them,” said John Brady, CEO, CentraForce Health. “I cannot imagine a stronger possible combination to address these insights than the combined strengths of Prealize and CentraForce Health.”